返回 Agenda
Session Chair(s)
John Kerridge, PHD, RPH
Director Of Quality, External Manufacturing Europe, Africa, Asia
LILLY FRANCE, France
Speaker(s)
European Commission – update on the FMD and implementation of provisions for active substances
Stefan Fuehring
European Commission, Belgium
Administrator
Stakeholder Perspective on Active Substance Control
Isabelle Clamou
European Commission, Belgium
Policy Officer, DG SANTE Unit D2
Regulator Perspective on Active Substance Control
Gerald W. Heddell
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Director, Inspection Enforcement & Standards Division